2025
Articles
19 November 2025
Sorrell-Gilbert Prize for research excellence in infectious diseases
Inaugural winners of the Sorrell-Gilbert Prize recognised for their outstanding 2024 research publications in basic science and public health research
16 October 2025
Simulating disease spread through evolution and opinion shifts
Sydney ID researchers from Engineering and Medicine and Health collaborate to explore how pathogen evolution and shifting public opinion affect disease spread
07 October 2025
SARS-CoV-2 infection: resistance is futile
This important discovery, supported by Sydney ID seed funding, sheds new light on how the virus evades immune detection
25 August 2025
Using AI to beat drug-resistant TB
Tuberculosis (TB) is the leading infectious disease killer in the world and most people with drug-resistant TB reside in Asia. AI analysis of TB genomes can help doctors to give patients optimal personalised treatment and allow public health teams to track how drug-resistant TB spreads in the community
01 July 2025
Co-designing HPV vaccination professional development for teachers and school staff: A Collaborative Approach with Key Stakeholders in Health and Education
Fulbright Fellow, Natalie McGowan, is working with Australian health and education experts to co-design HPV vaccine professional development for teachers—boosting vaccine literacy and helping Australia eliminate cervical cancer.
30 June 2025
New framework for emergency social media health communication to young people
Reaching younger audiences with accurate and engaging health information online is increasingly critical, especially during health emergencies where misinformation surges. This framework is the first of its kind, co-designed by young people and professional health communicators to help health organisations effectively engage young people in social media health communication.
30 January 2025
Vaccine patches are safe, effective and easy for older adults to use
Vaccine patches, which may be self-administered, are an alternative to vaccination with an injection. Our study used a vaccine-free patch with adults aged 50 and over showing they were safe, effective, easy to use.